Skip to main content
CDC Website

Long-Acting HIV Antiretroviral Therapy (ART): Cabotegravir/Rilpivirine (CAB/RPV)

This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine. 

Author:
NYC Department of Health and Mental Hygiene
Format:
Guideline
Publication Date:
2025
ID:
380432
  • Health Professionals
  • Nurses
  • Persons with HIV
  • Physicians
  • HIV and AIDS
  • Health Care Planning
  • HIV
  • Treatment Guidelines Materials
Was this page helpful? Give Feedback